Search research articles
Contact Us
Filters
Showing results (131-140 of 240) with videos related to
Page
of 24
Sort By:
Obstetrics and Gynecology
|
June 1, 1990
Management of endometrial cancer with suspected cervical involvement
R S Mannel, M L Berman, J L Walker, et al.
American Journal of Obstetrics and Gynecology
|
November 1, 1978
Toxicity manifestations following intravenous Corynebacterium parvum administration to patients with ovarian and cervical carcinoma
S A Gall, P J DiSaia, H Schmidt, et al.
Gynecologic Oncology
|
September 1, 1976
Adenocarcinoma of the endometrium: its metastatic lymph node potential. A preliminary report
W T Creasman, R C Boronow, C P Morrow, et al.
Obstetrics and Gynecology
|
March 1, 1990
The influence of endometriosis on the staging of cervical cancer
J L Walker, A Manetta, R S Mannel, et al.
Gynecologic Oncology
|
March 30, 1999
Management of ovarian cancer in patients older than 80 years of Age
N G Cloven, A Manetta, M L Berman, et al.
Gynecologic Oncology
|
October 1, 1993
To drain or not to drain: a retrospective study of closed-suction drainage following radical hysterectomy with pelvic lymphadenectomy
J K Jensen, J A Lucci, P J DiSaia, et al.
American Journal of Obstetrics and Gynecology
|
August 1, 1991
CA 125 regression: a model for epithelial ovarian cancer response
R E Buller, M L Berman, J D Bloss, et al.
Obstetrics and Gynecology
|
January 1, 1988
Relationship of serum CA125 and lipid-associated sialic acid tumor-associated antigen levels to the disease status of patients with gynecologic malignancies
J A Stratton, M A Rettenmaier, H B Phillips, et al.
American Journal of Clinical Oncology
|
August 1, 1986
Aminothiadiazole (NSC 4728) in patients with advanced ovarian carcinoma. A phase II study of the Gynecologic Oncology Group
R F Asbury, J Wilson, J A Blessing, et al.
Gynecologic Oncology
|
March 1, 1987
Phase III study on the treatment of women with cervical cancer, stage IIB, IIIB, and IVA (confined to the pelvis and/or periaortic nodes), with radiotherapy alone versus radiotherapy plus immunotherapy with intravenous Corynebacterium parvum: a Gynecologic Oncology Group Study
P J DiSaia, B N Bundy, S L Curry, et al.
Page
of 24
Search research articles
Search
Showing results (131-140 of 240) with videos related to
Sort By:
Page
of 24
Obstetrics and Gynecology
|
June 1, 1990
Management of endometrial cancer with suspected cervical involvement
R S Mannel, M L Berman, J L Walker, et al.
American Journal of Obstetrics and Gynecology
|
November 1, 1978
Toxicity manifestations following intravenous Corynebacterium parvum administration to patients with ovarian and cervical carcinoma
S A Gall, P J DiSaia, H Schmidt, et al.
Gynecologic Oncology
|
September 1, 1976
Adenocarcinoma of the endometrium: its metastatic lymph node potential. A preliminary report
W T Creasman, R C Boronow, C P Morrow, et al.
Obstetrics and Gynecology
|
March 1, 1990
The influence of endometriosis on the staging of cervical cancer
J L Walker, A Manetta, R S Mannel, et al.
Gynecologic Oncology
|
March 30, 1999
Management of ovarian cancer in patients older than 80 years of Age
N G Cloven, A Manetta, M L Berman, et al.
Gynecologic Oncology
|
October 1, 1993
To drain or not to drain: a retrospective study of closed-suction drainage following radical hysterectomy with pelvic lymphadenectomy
J K Jensen, J A Lucci, P J DiSaia, et al.
American Journal of Obstetrics and Gynecology
|
August 1, 1991
CA 125 regression: a model for epithelial ovarian cancer response
R E Buller, M L Berman, J D Bloss, et al.
Obstetrics and Gynecology
|
January 1, 1988
Relationship of serum CA125 and lipid-associated sialic acid tumor-associated antigen levels to the disease status of patients with gynecologic malignancies
J A Stratton, M A Rettenmaier, H B Phillips, et al.
American Journal of Clinical Oncology
|
August 1, 1986
Aminothiadiazole (NSC 4728) in patients with advanced ovarian carcinoma. A phase II study of the Gynecologic Oncology Group
R F Asbury, J Wilson, J A Blessing, et al.
Gynecologic Oncology
|
March 1, 1987
Phase III study on the treatment of women with cervical cancer, stage IIB, IIIB, and IVA (confined to the pelvis and/or periaortic nodes), with radiotherapy alone versus radiotherapy plus immunotherapy with intravenous Corynebacterium parvum: a Gynecologic Oncology Group Study
P J DiSaia, B N Bundy, S L Curry, et al.
Page
of 24